{
  "ticker": "GILD",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 50,
  "transactions": [
    {
      "id": 37332,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-30",
      "transaction_shares": "553",
      "transaction_price": "85.33",
      "transaction_type": "S",
      "shares_after_transaction": "45556"
    },
    {
      "id": 67569,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-30",
      "transaction_shares": "553",
      "transaction_price": "85.33",
      "transaction_type": "S",
      "shares_after_transaction": "45556"
    },
    {
      "id": 107208,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-30",
      "transaction_shares": "553",
      "transaction_price": "85.33",
      "transaction_type": "S",
      "shares_after_transaction": "45556"
    },
    {
      "id": 153417,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-30",
      "transaction_shares": "553",
      "transaction_price": "85.33",
      "transaction_type": "S",
      "shares_after_transaction": "45556"
    },
    {
      "id": 206678,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-30",
      "transaction_shares": "553",
      "transaction_price": "85.33",
      "transaction_type": "S",
      "shares_after_transaction": "45556"
    },
    {
      "id": 37313,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1039",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "46595"
    },
    {
      "id": 37316,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "69695"
    },
    {
      "id": 37326,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "318",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "28651"
    },
    {
      "id": 37328,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "990",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40893"
    },
    {
      "id": 37346,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "3300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "256178"
    },
    {
      "id": 67540,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1039",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "46595"
    },
    {
      "id": 67544,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "69695"
    },
    {
      "id": 67560,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "318",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "28651"
    },
    {
      "id": 67565,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "990",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40893"
    },
    {
      "id": 67589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "3300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "256178"
    },
    {
      "id": 107170,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1039",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "46595"
    },
    {
      "id": 107174,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "69695"
    },
    {
      "id": 107196,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "318",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "28651"
    },
    {
      "id": 107204,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "990",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40893"
    },
    {
      "id": 107236,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "3300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "256178"
    },
    {
      "id": 153373,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1039",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "46595"
    },
    {
      "id": 153378,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "69695"
    },
    {
      "id": 153403,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "318",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "28651"
    },
    {
      "id": 153411,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "990",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40893"
    },
    {
      "id": 153450,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "3300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "256178"
    },
    {
      "id": 206629,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1039",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "46595"
    },
    {
      "id": 206634,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "1027",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "69695"
    },
    {
      "id": 206662,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "318",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "28651"
    },
    {
      "id": 206670,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2022-12-10",
      "transaction_shares": "990",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40893"
    },
    {
      "id": 206714,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-10",
      "transaction_shares": "3300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "256178"
    },
    {
      "id": 37320,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "5099",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "47824"
    },
    {
      "id": 37331,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "1912",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "69519"
    },
    {
      "id": 67552,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "5099",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "47824"
    },
    {
      "id": 67568,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "1912",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "69519"
    },
    {
      "id": 107186,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "5099",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "47824"
    },
    {
      "id": 107207,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "1912",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "69519"
    },
    {
      "id": 153392,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "5099",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "47824"
    },
    {
      "id": 153414,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "1912",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "69519"
    },
    {
      "id": 206649,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "5099",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "47824"
    },
    {
      "id": 206675,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-11-10",
      "transaction_shares": "1912",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "69519"
    },
    {
      "id": 37325,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-09",
      "transaction_shares": "6416",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "34749"
    },
    {
      "id": 67558,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-09",
      "transaction_shares": "6416",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "34749"
    },
    {
      "id": 107194,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-09",
      "transaction_shares": "6416",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "34749"
    },
    {
      "id": 153401,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-09",
      "transaction_shares": "6416",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "34749"
    },
    {
      "id": 206659,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-09",
      "transaction_shares": "6416",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "34749"
    },
    {
      "id": 37307,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "16255",
      "transaction_price": "72.70",
      "transaction_type": "M",
      "shares_after_transaction": "44588"
    },
    {
      "id": 67529,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "16255",
      "transaction_price": "72.70",
      "transaction_type": "M",
      "shares_after_transaction": "44588"
    },
    {
      "id": 107158,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "16255",
      "transaction_price": "72.70",
      "transaction_type": "M",
      "shares_after_transaction": "44588"
    },
    {
      "id": 153361,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "16255",
      "transaction_price": "72.70",
      "transaction_type": "M",
      "shares_after_transaction": "44588"
    },
    {
      "id": 206616,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "16255",
      "transaction_price": "72.70",
      "transaction_type": "M",
      "shares_after_transaction": "44588"
    }
  ]
}